Publication Name	World Journal of Gastroenterology
Manuscript ID	6016
Country	United Kingdom

Received	2013-09-29 18:37
Peer-Review Started	2013-09-30 17:03
To Make the First Decision	2013-10-29 12:43
Return for Revision	2013-11-01 16:50
Revised	2013-12-16 19:12
Second Decision	2014-06-26 16:59
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-26 17:29
Articles in Press	2014-06-26 17:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-25 21:51
Publish the Manuscript Online	2014-10-16 15:53

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Systematic Reviews
Article Title	Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases
Manuscript Source	Invited Manuscript
All Author List	Reza Mirnezami, Brendan J Moran, Kate Harvey, Tom Cecil, Kandiah Chandrakumaran, Norman Carr, Faheez Mohamed and Alexander H Mirnezami
Funding Agency and Grant Number	Funding Agency Grant Number Cancer Research United Kingdom Wessex Medical Research
Corresponding Author	Dr. Alexander H Mirnezami, Somers Cancer Research Building, University of Southampton Cancer Sciences Division, Southampton University Hospital NHS Trust, Tremona Road, Southampton SO166YD, United Kingdom. ahm@soton.ac.uk
Key Words	Colorectal cancer; Peritoneal metastasis; Cytoreductive surgery; Intraperitoneal chemotherapy; Hyperthermic intraperitoneal chemotherapy
Core Tip	Colorectal cancer peritoneal metastases (CPM) confer a dismal prognosis and traditional treatment involving systemic chemotherapy, with or without palliative surgery has poor outcomes. Cytoreductive surgery (CRS) combined with intraperitoneal chemotherapy (IPC) is now advocated for selected patients with CPM. The present study provides a comprehensive summary of the available evidence relating to CRS in combination with IPC in the setting of CPM, focusing on techniques, oncological outcomes, and complications.
Publish Date	2014-10-16 15:53
Citation	Mirnezami R, Moran BJ, Harvey K, Cecil T, Chandrakumaran K, Carr N, Mohamed F, Mirnezami AH. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases. World J Gastroenterol 2014; 20(38): 14018-14032
URL	http://www.wjgnet.com/1007-9327/full/v20/i38/14018.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i38.14018

Full Article (PDF)	WJG-20-14018.pdf
Full Article (Word)	WJG-20-14018.doc
Manuscript File	6016-Review.docx
Answering Reviewers	6016-Answering reviewers.pdf
Copyright License Agreement	6016-Copyright assignment.pdf
Peer-review Report	6016-Peer review.pdf
Scientific Misconduct Check	6016-CorssCheck.jpg
Scientific Editor Work List	6016-Scientific editor work list.pdf